Home
overview

Following the success of our inaugural KOL conference in London last year, and the continued success of our event in Munich in June, SMi are proud to announce the return of our KOL series to London with our 2nd Annual KOL: Knowledge Leaders conference in September.

The interaction between key academics/physicians and industry is a vital part of any marketing strategy to commercialise a new drug.  The identification and management of such key opinion leaders can be both challenging and rewarding for all involved.

With controversy surrounding these interactions SMi’s 2nd Annual KOL conference in London aims to focus on getting the relationship right between industry and academia.  With leading opinion leaders giving their perspective alongside discussions from those in industry tasked with forging these relationships, this conference is a must attend event.

Allowing for plenty of discussion within the programme this conference is unique in providing an ideal platform to obtain the building blocks needed for successful KOL interactions, whilst offering networking opportunities throughout the day.

Help to dispel some of the myths that blight the public perception of these relationships by participating in healthy debate and discussion about the way to move forward with these essential exchanges.
 

  1. Hear the perspectives of the opinion leaders
  2. Obtain insight into the opinions of patient groups
  3. Learn about the best ways to conduct an industry-physician relationship
  4. Discuss your views with the experts in our breakout sessions

Last year's KOL London 2008 conference attracted the following professionals:

  • Head of Customer Relationship Management, Bayer-Schering AG
  • Director Scientific Communications, GlaxoSmithKline UK
  • Head of Medical & Scientific Affairs, Boehringer Ingelheim
  • Assistant Vice President, Opinion Leader Relations, Wyeth USA
  • Professional Relations, Roche
  • Associate Branding Director, Astellas Europe
  • Manager Medical Affairs, Linde AG
  • Marketing Director EMEA, Allergan
  • Medical Director, Bayer
  • Medical Director, Pfizer
  • Associate Medical Director, Cilag Biotech
  • Product Director, International Marketing, Shire Pharmaceuticals
  • Director, Regional Medical Liaisons, Amgen Inc.
  • Clinical Director, Astra Zeneca
  • Vice President Global Sales & Marketing, Covidien
  • New Product Manager, Global Marketing, Laboratorios Almirall S.A.
  • Professional Relations Manager, Medical & Healthcare, Lundbeck
  • Medical Marketing Manager, Genzyme Europe

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Jon Stamford

Jon Stamford, Honorary Reader in Pyschology, University of Leicester

9:10 KEYNOTE PRESENTATION: THE KOL PERSPECTIVE

Iain Macdougall

Iain Macdougall, Consultant Nephrologist and Honorary Senior Lecturer, King's College Hospital

  • Benefits to practitioners of a relationship with industry
  • Drawbacks and difficulties
  • Maintaining personal integrity
  • The issue of ethics
  • 9:50 THE KOL RELATIONSHIP

    Jon Stamford

    Jon Stamford, Honorary Reader in Pyschology, University of Leicester

  • Research and publication - two distinct skill sets?
  • Academia and editorial - best of both worlds or an impossible tightrope?
  • Real and imagined conflicts of interest
  • The need for better understanding and reciprocity
  • Why are there so few basic science KOLs?
  • 10:30 Morning Coffee

    11:00 INSIGHTS INTO THE KOL/INDUSTRY RELATIONSHIP

    Alan Morris

    Alan Morris, Head of Client Services, Complete Medical Communications

  • Learnings from insight research with KOLs
  • How do KOLs see the relationship now - what works well / not so well
  • How do KOLs want the relationship to evolve in the future
  • Learnings from reaction to the BMJ article on industry working with KOLs, June 2008
  • 11:40 NEUROSCIENCE

    Mary Baker

    Mary Baker, President, European Federation of Neurological Associations

    Threats:

  • Demographic changes
  • Change in the role of women
  • Migration
  • Opportunities:

  • Working with the Commission
  • Pharmaceutical Industry
  • Partnership and Innovation
  • 12:20 Networking Lunch

    13:50 BREAKOUT SESSIONS

    14:50 Afternoon Tea

    15:20 ARE KEY OPINION LEADERS GOOD FOR MEDICINE?

    Fiona Godlee

    Fiona Godlee, Editor-in-Chief, BMJ

  • Should doctors be involved with industry?
  • The issue of transparency
  • The impact of these relationships on science & healthcare
  • Advice to individuals
  • 16:00 BASIC SCIENCE RESEARCH

    Charles Bennett MD PhD MPP

    Charles Bennett MD PhD MPP, AC Buehler Professor of Geriatrics and Economics, Northwestern University

  • History of pharmaceutical sponsorship of basic science research
  • Is there evidence of financial conflicts of interest in basic science research?
  • Why conflicts of interest considerations differ between basic and clinical science
  • Is transparency really the answer?
  • 16:40 Chairman’s Closing Remarks

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Kevin Curry

    Kevin Curry, Senior Medical Adviser, Boehringer Ingelheim

    9:10 KEYNOTE ADDRESS: MEDICAL PRODUCT MONEY IN MEDICINE: SIN OR SALVATION?

    Tom Stossel

    Tom Stossel, Professor, Harvard Medical School

  • Mutual mistrust of physicians and industry is damaging for relationships
  • More red tape for industry means limits on drug development
  • Fair promotion of products is not immoral
  • 9:50 TO BE OR NOT TO BE, THAT IS THE QUESTION

    Georgina Butcher

    Georgina Butcher, Senior Manager Business Intelligence, Chugai Pharma Europe

  • What is the nature of the role of an expert/KOL in the development process?
  • How does this role differ through the development phase - particularly the industry/expert roles at late research to early development (PI/II)
  • What can be gained from this relationship in the early stages? Industry? Expert?
  • What issues arise?
  • How can we build on the positive aspects of the relationship?
  • 10:30 Morning Coffee

    11:00 THE LONG-TERM VIEW

    Kevin Curry

    Kevin Curry, Senior Medical Adviser, Boehringer Ingelheim

  • Finding KOLs to work with for that time can be difficult
  • Predicting science for the duration of an R&D project is challenging
  • The challenge of maintaining a long term relationship
  • Predicting the importance of KOL for the length of the project
  • 11:40 EXERIENCES IN THE MEDICAL DEVICE INDUSTRY

    Angela Saulino

    Angela Saulino, Director, Peer to Peer, Covidien

  • Working with multiple products and international locations
  • KOL identification
  • Compliance issues
  • Unique challenges of the medical device industry
  • Lessons learned
  • 12:20 Networking Lunch

    13:50 PANEL DISCUSSION

  • Public perception of the KOL-industry relationship can be unfavourable
  • What can be done to improve this perception?
  • How should a KOL respond to accusations?
  • Is transparency really the answer?
  • Philippe Fonjallaz

    Philippe Fonjallaz, Program Partner, Scientific Relations, Merck Serono

    Tom Stossel

    Tom Stossel, Professor, Harvard Medical School

    14:30 HOW DO YOU MOTIVATE PHYSICIANS TO WORK WITH YOU?

    Philippe Fonjallaz

    Philippe Fonjallaz, Program Partner, Scientific Relations, Merck Serono

  • Sharing challenges
  • Partnership of experts
  • Sharing recognition
  • 15:10 CASE STUDY: ONCOLOGY KOLS

    Daniel Davis

    Daniel Davis, Clinical Operations Manager, Eli Lilly & Company

  • KOLs in oncology are heavily invested in research
  • They have needs from industry that differ from other therapeutic areas
  • New model developed to augment current roles (MSLs) and create some new ones (CDL) and address this need
  • 15:40 Final Questions & Chairman’s Closing Remarks

    16:00 Afternoon Tea

    +

    Workshops

    KOL Relationship Management & Segmentation
    Workshop

    KOL Relationship Management & Segmentation

    Crowne Plaza Hotel - St James
    29th September 2009
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.